HER2-PREDICT: Translational Study of Tumor Samples From Patients Treated With Trastuzumab Deruxtecan (T-DXd; DS-8201a)
Clinical trial NCT04257162 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04257162
- Sponsor
- SOLTI Breast Cancer Research Group
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-13
- Primary completion
- 2025-06-30
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.